When was Enzo founded?

Enzo was founded in 1976 and raised its 1st funding round 47 years after it was founded.

Where is Enzo located?

Enzo is headquartered in Farmingdale, United States.

Who is the current CEO of Enzo?

Elazar Rabbani and Carl W. Balezentis s of Enzo.

How many employees does Enzo have?

As of Aug 31, 2026, the latest employee count at Enzo is 74.

Is Enzo a funded company?

Enzo is a funded company, having raised a total of $***** in its 1st and only funding round, a Unattributed round on May 19, 2023.

How much is Enzo worth?

The last known valuation of Enzo was $***** as of Jun 24, 2025.

When was the latest funding round of Enzo?

Enzo's latest funding was a $***** Unattributed round on May 19, 2023, with participation from 0 investor.

What is the annual revenue of Enzo?

Annual revenue of Enzo is between $10M and $50M as on Jul 31, 2024

Where does Enzo rank among its competitors?

Enzo ranks 3rd amongst 951 active competitors, of which 61 are funded. It stands 6th in terms of total funding among its competitors. The most recent competitor to raise funding was BioLamina, which secured $23.6M in Apr, 2026.

Who are the top competitors of Enzo?

Enzo's top competitors include Abcam, Meridian Bioscience and Sino Biological. Among them, BioLamina secured the most recent funding round in April, 2026.

Enzo - 2026 Company Profile, Team, Funding, Competitors & Financials

Q: Is Enzo an acquired company?

Enzo got acquired by Battery Ventures on Jun 24, 2025.

Enzo is an acquired company based in Farmingdale (United States), founded in 1976 by Barry Weiner and Elazar Rabbani. It operates as a Life science products and services for research, drug discovery, and manufacturing. Enzo has raised $7M in funding, with last known valuation of $*****. The company has 951 active competitors, including 61 funded and 125 that have exited. Its top competitors include companies like Abcam, Meridian Bioscience and Sino Biological.

Company Details

Life science products and services for research, drug discovery, and manufacturing. The company provides a wide array of basic research products, including RNA probes, antibodies, immunoassays, and cell-based assays. It offers technology platforms for genomic, protein, cellular, and tissue analysis, along with small molecule chemistry solutions. Serving academic research, biotech, pharma, CROs, and diagnostic manufacturers, the company supports biopharma product development from target identification to biomarker expression. It provides services like analytical testing, custom antibody, protein, and oligo services, and GMP manufacturing. The company focuses on enabling therapeutics through immune regulation, gene technologies, and cell signaling modulation, offering licensing opportunities. It emphasizes manufacturing quality with GMP, ISO , and ISO certifications, ensuring high-quality products and services for advancing research and clinical trials. The company also provides resources like blogs, scientific literature, application notes, and webinars.

Website: www.enzo.com
Social
Email ID: *****@enzo.com

Key Metrics

Founded Year

1976

Location

Farmingdale, United States

Stage

Acquired

Total Funding

$7M in 1 round

Latest Funding Round

Unattributed, May 19, 2023, $*****

Last Known Valuation

$***** as on Jun 24, 2025

Ranked

3^rd among 951 active competitors

Annual Revenue

$10M - $50M as on Jul 31, 2024

Employee Count

74 as on Aug 31, 2026

Investment & Acquisitions

Asssay Designs & 1 more

Similar Companies

Abcam & 1121 more

Exit Details

Acquired by Battery Ventures (Jun 24, 2025)

View Enzo's full profile

Enzo is associated with 1 legal entity given below:

Legal Entity Name	Date of Incorporation	Revenue	Latest Employee Count	Documents
Enzo Biochem Inc CIN: 316253 , United States, Active		$10M - $50M (As on Jul 31, 2024)	179 (As on Dec 31, 2023)	-

Enzo got acquired by Battery Ventures on Jun 24, 2025 at an acquisition amount of $*****.

Click here to take a look at Enzo's acquisition in detail

Enzo has raised a total funding of $7M over 1 round.

Here is the list of recent funding rounds of Enzo:

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
May 19, 2023	4518741	Unattributed	7617101	9765661	3982482	5131222

Access funding benchmarks and valuations. Sign up today!

View details of Enzo's funding rounds and investors

The founders of Enzo are Barry Weiner and Elazar Rabbani.

Here are the details of Enzo's key team members:

Barry Weiner: Co-Founder & CFO of Enzo.
Contact Info: 1 email address
Elazar Rabbani: Co-Founder & CEO of Enzo.
Contact Info: 1 email address
Carl W. Balezentis: CEO of Enzo.

View details of Enzo's Founder profiles and Board Members

Enzo's employee count trend

Enzo has 74 employees as of Aug 26. Here is Enzo's employee count trend over the years:

Uncover Enzo's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Enzo include Abcam, Meridian Bioscience and Sino Biological. Here is the list of Top 10 competitors of Enzo, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Abcam 1998, Cambridge (United Kingdom), Acquired	Developer of biological reagents for life science research	$78.8M	Juno Investment Partners, Martlet Capital ... & 2 others	76/100
2nd	Meridian Bioscience 1976, Ohio (United States), Acquired	Molecular diagnostic device and kits	-	JobsOhio, NIH	65/100
3rd	Enzo 1976, Farmingdale (United States), Acquired	Life science products and services for research, drug discovery, and manufacturing	$7M	-	65/100
4th	Sino Biological 2007, Beijing (China), Series A	Provider of reagents,and kits for clinical research	$29.4M	Qiming Venture Partners, CTS Capital & 1 others	63/100
5th	Devyser 2004, Stockholm (Sweden), Public	Provider of molecular diagnostic kits for cancer, hereditary diseases, and reproductive disorders	$15.5M	Swedbank Robur, Fjarde AP-fonden & 1 others	61/100
6th	Huwel Life 2015, Hyderabad (India), Series A	Molecular diagnostic solutions and products for the healthcare industry	$5.74M	Bartronics, BIRAC & 3 others	59/100
7th	Miltenyi Biotec 1989, Bergisch Gladbach (Germany), Funding Raised	Develops tools and products for research and clinical application	-	Europa, HHS	58/100
8th	Stem Cell Technologies 1993, Vancouver (Canada), Series A	Developer of cell culture media and ancillary reagents for life science research	$11.9M	National Research Council Canada, Europa & 1 others	58/100
9th	BioIVT 1981, Westbury (United States), Acquired	Provider of in vitro diagnostic products and assay services	-	WILsquare Capital, Europa & 4 others	56/100
10th	BioLamina 2008, Sundbyberg (Sweden), Series B	Cell culture reagents for stem cell research	$18.2M	Lauxera Capital Partners, Bure Equity & 5 others	56/100